Abstract
A 68-year-old women was admitted with the chief complaints of epigastralgia with radiation to the back and jaundice. Fever and chills were also noted. The laboratory data showed alkaline phosphatase, 245 U/L (normal range: 28–94); Direct Bilirubin, 5.29 mg% (0–0.4); Total Bilirubin, 8.4 mg% (0.2–1.4). Surprisingly, the serum CA19-9 was 5673.8 U/ml (normal value: <37). Abdominal sonography showed dilated common hepatic duct. MRCP demonstrated diffuse biliary tree dilatation with a very low signal intensity in distal common bile duct. Surgical intervention reveled a black stone at distal common bile duct and was successfully retrieved. After operation, the CA19-9 fell to 63.1 u/ml two weeks later and returned to normal (10.4 U/ml) one month later.
Similar content being viewed by others
References
Koprowski H, Steplewski Z, Mitchell K, et al. (1981) Specific antigen in serum of patients with colon carcinoma. Science 212:53–55
Savarinu V (1984) Evaluation of a new tumor-antigen in pancreatic cancer. Digestion 22:1–5
Yoshikawa T, Nishida K, Tanigawa M, et al. (1985) Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancy. Digestion 31:67–76
Arends JW, Verstynen C, Bosman FT, et al. (1983) Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissue: an immunoperoxidase study. Hybridoma 2:219–229
McFarlane IG (1983) Hepatic clearance of serum glycoproteins. Clin Sci 64:127–135
Steinberg WM (1990) The clinical utility of the CA19-9 tumor-associated antigen. Am J Gastroenterol 85:350–355
Changchien CS, Yung CY, Tzen KY (1991) Serum CEA and CA 19-9 value in patients with pancreatic cancer or pancreatitis. Chang Gung Med J 14:32–38
Craxi A, Patti C, Aragona E (1985) Serum CA19-9 levels in patients with hepatocellular carcinoma or cirrhosis. Ital J Gastroenterol 17:288–289
Tolliver BA, O’Brien BL (1997) Elevated tumor-associated antigen CA19-9 in a patient with an enlarged pancreas: does it always imply malignancy? Southern Med J 90:89–90
Kim HJ, Kim MH, Myung SJ, et al. (1999) A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using receive operating characteristic curve. Am J Gastroenterol 94:1941–1946
Murohisa T, Sugaya H, Tetsuka I, et al. (1992) A case of common bile duct stone with cholangitis presenting an extraordinary high serum CA19-9 value. Int Med 31:516–520
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sheen-Chen, SM., Sun, CK., Liu, YW. et al. Extremely Elevated CA19-9 in Acute Cholangitis. Dig Dis Sci 52, 3140–3142 (2007). https://doi.org/10.1007/s10620-006-9164-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9164-7